Serum procalcitonin in Egyptian patients with acute meningitis and a negative direct cerebrospinal fluid examination.
BACKGROUND
To reduce the morbidity and mortality related to bacterial meningitis, it is important to discriminate bacterial meningitis from aseptic meningitis during the acute phase of the disease, when the clinical symptoms are often similar.


OBJECTIVE
To test the reliability of serum procalcitonin (PCT) to discriminate bacterial meningitis from aseptic meningitis in patients who have a negative direct cerebrospinal fluid (CSF) examination, and to evaluate the role of serum PCT to assess treatment efficacy compared with the total leukocyte count (TLC), erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP).


METHODS
Forty patients with suspected acute meningitis and negative gram stains were included, and ten healthy persons were included as controls. According to the clinical examination and the CSF cytochemical analysis and cultures, the patients were divided into bacterial and aseptic groups. The measurements of serum PCT, ESR, CRP and TLC were performed.


RESULTS
Patients in the bacterial group had a higher value of serum PCT at admission and at 3 days post-treatment than those in the aseptic group, with a highly significant difference between them.


CONCLUSIONS
Serum PCT and, to a lesser extent, TLC had prognostic value in patients with acute meningitis, and PCT is more useful because it can be frequently measured for the diagnosis and follow-up of bacterial meningitis.
Tropical Medicine and Clinical Pathology Departments, Faculty of Medicine/Ain Shams University, Cairo 11566, Egypt.
Nadia A
NA
Abdelkader
Tropical Medicine and Clinical Pathology Departments, Faculty of Medicine/Ain Shams University, Cairo 11566, Egypt.
Waheed A
WA
Mahmoud
Tropical Medicine and Clinical Pathology Departments, Faculty of Medicine/Ain Shams University, Cairo 11566, Egypt. Electronic address: sallysaber@ymail.com.
Sally Mohamed
SM
Saber
D000293:Adolescent; D000328:Adult; D000368:Aged; D002116:Calcitonin / Q000097:blood*; D015740:Calcitonin Gene-Related Peptide; D002555:Cerebrospinal Fluid / Q000737:chemistry*; D003937:Diagnosis, Differential; D003955:Diagnostic Tests, Routine / Q000379:methods*; D016903:Drug Monitoring / Q000379:methods*; D004534:Egypt; D005260:Female; D006801:Humans; D008297:Male; D008581:Meningitis / Q000175:diagnosis* / Q000473:pathology; D008582:Meningitis, Aseptic / Q000175:diagnosis* / Q000473:pathology; D008875:Middle Aged; D011446:Prospective Studies; D011498:Protein Precursors / Q000097:blood*; D044967:Serum / Q000737:chemistry*; D055815:Young Adult
C000606589:CALCA protein, human; D011498:Protein Precursors; D002116:Calcitonin; D015740:Calcitonin Gene-Related Peptide
Acute meningitis; Negative gram stain; Procalcitonin